Systematic Review and Network Meta-Analysis of Anaplastic Lymphoma Kinase (ALK) Inhibitors for Treatment-Naïve ALK-Positive Lung Cancer

SIMPLE SUMMARY: The prognosis of non-small cell lung cancer (NSCLC) is poor as more than half of the patients are diagnosed at an advanced stage. The outcomes have greatly improved in the recent two decades due to the introduction of target therapy. Anaplastic lymphoma kinase (ALK) rearrangement is...

Descripción completa

Detalles Bibliográficos
Autores principales: Chuang, Cheng-Hao, Chen, Hsiao-Ling, Chang, Hsiu-Mei, Tsai, Yu-Chen, Wu, Kuan-Li, Chen, I-Hua, Chen, Kung-Chao, Lee, Jui-Ying, Chang, Yong-Chieh, Chen, Chin-Ling, Tu, Yu-Kang, Hung, Jen-Yu, Yang, Chih-Jen, Chong, Inn-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072703/
https://www.ncbi.nlm.nih.gov/pubmed/33921762
http://dx.doi.org/10.3390/cancers13081966

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072703/
https://www.ncbi.nlm.nih.gov/pubmed/33921762
http://dx.doi.org/10.3390/cancers13081966

Ejemplares similares